Beneficial effect of synbiotics on experimental colon cancer in rats
- PMID: 30249566
- PMCID: PMC6284644
- DOI: 10.5152/tjg.2018.17469
Beneficial effect of synbiotics on experimental colon cancer in rats
Abstract
Background/aims: The aim of this study was to investigate the influence of a synbiotic preparation (a mixture of six probiotics and a prebiotic) on aberrant crypt foci (ACF) formation, dysplasia, inflammation, and colitis-like lesions in experimental colon cancer in rats.
Materials and methods: Sixty male rats were categorized into three groups of 20 animals each. Group A was administered 1,2-dimethylydrazine, 15 mg/kg body weight (BW), once a week for 2 weeks. Group B was administered 1,2-dimethylydrazine at the same dose plus synbiotic, started after the second dose of carcinogen and lasted for 5 weeks. Group C was administered synbiotic plus carcinogen from the beginning of the experiment and lasted for 7 weeks. Animals were killed at the end of week 7.
Results: At the end of the experiment, the animals that received carcinogen plus the synbiotic had 100%, whereas the animals that received only carcinogen has 70% survival. Animals of groups B and C had significantly lower percentage of inflammation, colitis-like lesions, and ACF dysplasia than animals of group A, whereas those of group C had the least pathological lesions.
Conclusion: Synbiotics seem to protect against the appearance of preneoplastic colon lesions in rats. The results of this experimental study suggest that treatment with a synbiotic preparation exerts significant antimutagenic properties against the development of preneoplastic lesions in rats.
Conflict of interest statement
Figures











Similar articles
-
Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.Hum Exp Toxicol. 2008 Jun;27(6):505-11. doi: 10.1177/0960327108091862. Hum Exp Toxicol. 2008. PMID: 18784204
-
Silibinin modulates biotransforming microbial enzymes and prevents 1,2-dimethylhydrazine-induced preneoplastic changes in experimental colon cancer.Eur J Cancer Prev. 2009 Sep;18(5):385-94. doi: 10.1097/CEJ.0b013e32832d1b4f. Eur J Cancer Prev. 2009. PMID: 19654488
-
Arabinoxylan-oligosaccharides (AXOS) reduce preneoplastic lesions in the colon of rats treated with 1,2-dimethylhydrazine (DMH).Eur J Nutr. 2010 Mar;49(2):127-32. doi: 10.1007/s00394-009-0050-x. Epub 2009 Aug 27. Eur J Nutr. 2010. PMID: 19711111
-
Inhibition of intestinal tumor development in rat multi-organ carcinogenesis and aberrant crypt foci in rat colon carcinogenesis by 22-oxa-calcitriol, a synthetic analogue of 1 alpha, 25-dihydroxyvitamin D3.Carcinogenesis. 1995 Sep;16(9):2091-7. doi: 10.1093/carcin/16.9.2091. Carcinogenesis. 1995. PMID: 7554059
-
Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1,2-dimethylhydrazine in rat colon.Toxicol Pathol. 2008 Jun;36(4):576-80. doi: 10.1177/0192623308317423. Epub 2008 May 8. Toxicol Pathol. 2008. PMID: 18467683
Cited by
-
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment.Intest Res. 2022 Jan;20(1):31-42. doi: 10.5217/ir.2021.00034. Epub 2021 May 21. Intest Res. 2022. PMID: 34015206 Free PMC article. Review.
-
Evaluation of skin cancer prevention properties of probiotics.Genes Nutr. 2025 May 23;20(1):12. doi: 10.1186/s12263-025-00770-z. Genes Nutr. 2025. PMID: 40410666 Free PMC article. Review.
-
Effect of a Diet Supplemented with Sphingomyelin and Probiotics on Colon Cancer Development in Mice.Probiotics Antimicrob Proteins. 2022 Jun;14(3):407-414. doi: 10.1007/s12602-022-09916-6. Epub 2022 Feb 2. Probiotics Antimicrob Proteins. 2022. PMID: 35112298 Free PMC article.
References
-
- Foo NP, Ou Yang H, Chiu HH, et al. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem. 2011;59:13337–45. doi: 10.1021/jf203444d. - DOI - PubMed
-
- Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C, De Simone C. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol. 2011;301:G1004–13. doi: 10.1152/ajpgi.00167.2011. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources